keyword
https://read.qxmd.com/read/38651563/local-alpha1-antitrypsin-accelerates-the-healing-of-tympanic-membrane-perforation-in-mice
#1
JOURNAL ARTICLE
Sabri El-Saied, Amit Amar, Daniel M Kaplan, Rivka Shitrit, Benyamin M Kaminer, Aharon Keshet, Eli C Lewis
BACKGROUND: Most tympanic membrane (TM) perforations heal spontaneously, but 10%-20% remain chronic and might lead to impaired hearing and recurrent middle ear infections. Alpha1-antitrypsin (AAT) is a circulating tissue-protective protein that is elevated under inflammatory conditions and is currently indicated for genetic AAT deficiency. Recently, AAT has been shown to promote tissue remodeling and inflammatory resolution. OBJECTIVE: This study aimed to examine the effects of local clinical-grade AAT treatment on tissue repair in a mouse model of acute traumatic TM perforation...
April 23, 2024: Laryngoscope
https://read.qxmd.com/read/38651364/integrating-in%C3%A2-vivo-and-ex%C3%A2-vivo-approaches-for-culprit-drug-identification-in-cutaneous-adverse-drug-reactions-from-non-beta-lactam-antibiotics
#2
JOURNAL ARTICLE
Narumol Ratanasutiranont, Pungjai Mongkolpathumrat, Patcharapong Rujirawan, Pawinee Rerknimitr, Jettanong Klaewsongkram
No abstract text is available yet for this article.
April 2024: Experimental Dermatology
https://read.qxmd.com/read/38651345/a-4-gene-prognostic-index-for-enhancing-acute-myeloid-leukaemia-survival-prediction
#3
JOURNAL ARTICLE
Cesar Alexander Ortiz Rojas, Diego Antonio Pereira-Martins, Candy Christie Bellido More, Dominique Sternadt, Isabel Weinhäuser, Jacobien R Hilberink, Juan Luiz Coelho-Silva, Carolina Hassibe Thomé, Germano Aguiar Ferreira, Emanuele Ammatuna, Gerwin Huls, Peter J Valk, Jan Jacob Schuringa, Eduardo Magalhães Rego
Despite advancements in utilizing genetic markers to enhance acute myeloid leukaemia (AML) outcome prediction, significant disease heterogeneity persists, hindering clinical management. To refine survival predictions, we assessed the transcriptome of non-acute promyelocytic leukaemia chemotherapy-treated AML patients from five cohorts (n = 975). This led to the identification of a 4-gene prognostic index (4-PI) comprising CYP2E1, DHCR7, IL2RA and SQLE. The 4-PI effectively stratified patients into risk categories, with the high 4-PI group exhibiting TP53 mutations and cholesterol biosynthesis signatures...
April 23, 2024: British Journal of Haematology
https://read.qxmd.com/read/38651340/adverse-reactions-after-intravascular-iodinated-contrast-media-administration-and-their-management
#4
JOURNAL ARTICLE
Mária Rašiová, Oliver Schlager, Christian Heiss, Marianne Brodmann, Dan Mircea Olinic, Vinko Boc, Giacomo Buso, Jill Belch, Lucia Mazzolai, Juraj Madaric
<b/>Endovascular interventions and diagnostic examinations using iodinated contrast media (ICM) are standard of care in current vascular medicine. Although ICM use is generally considered safe, it may be associated with adverse reactions, vary from minor disturbances to rare, but severe life-threatening complications. This position paper of European Society of Vascular Medicine integrates current knowledge and summarizes the key information related to the use of intravascular ICM, serving as recommendation on prevention and management of acute, late, and very late adverse reactions...
April 23, 2024: VASA. Zeitschrift Für Gefässkrankheiten
https://read.qxmd.com/read/38651283/postmarket-safety-communications-on-drugs-approved-in-japan-a-25-year-analysis
#5
JOURNAL ARTICLE
Yusuke Tanaka, Mototsugu Tanaka, Haruna Miyazawa, Ryohei Terashima, Makoto Miyazawa, Mutsuhiro Ikuma, Yoshihiko Tomita
Drug safety communications (DSCs) are essential tools for communicating important postmarket serious drug safety information to healthcare professionals and patients. Previous studies characterized DSCs issued by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA); however, knowledge about the activities of the Pharmaceuticals and Medical Devices Agency (PMDA)/the Ministry of Health, Labor and Welfare (MHLW) is limited. This study characterized DSCs by the PMDA/MHLW in comparison with previously reported DSCs by the FDA and the EMA...
April 2024: Clinical and Translational Science
https://read.qxmd.com/read/38651280/hepatic-artery-infusion-chemotherapy-combined-with-the-folfox-regimen-for-the-treatment-of-hepatocellular-carcinoma-recent-advances-and-literature-review
#6
REVIEW
Suqi Zhu, Yahan Yu, Mingqi Yang, Xin Liu, Mingkai Lai, Jieren Zhong, Xiaoguang Zhao, Ligong Lu, Yanyan Liu
INTRODUCTION: The incidence of primary liver cancer (PLC) has experienced a significant global increase, primarily attributed to the rise in hepatocellular carcinoma (HCC). Unfortunately, HCC is often diagnosed in advanced stages, leaving patients with limited treatment options. Therefore, transformation therapy is a crucial approach for long-term survival and radical resection in patients with advanced HCC. Conversion therapy has demonstrated promise in the treatment of advanced HCC...
April 23, 2024: Expert Review of Anticancer Therapy
https://read.qxmd.com/read/38651254/dual-targeted-novel-temozolomide-nanocapsules-encapsulating-sipkm2-inhibit-aerobic-glycolysis-to-sensitize-glioblastoma-to-chemotherapy
#7
JOURNAL ARTICLE
Yongkang Zhang, Hongwei Ma, Linsen Li, Chen Sun, Changshui Yu, Lansheng Wang, Duo Xu, Xu Song, Rutong Yu
Chemotherapy of glioblastoma (GBM) has not yielded success due to inefficient blood-brain barrier (BBB) penetration and poor glioma tissue accumulation. Aerobic glycolysis, as the main mode of energy supply for GBM, safeguards the rapid growth and proliferation of GBM while affecting the efficacy of radiotherapy and chemotherapy. Therefore, to effectively inhibit aerobic glycolysis, increase drug delivery efficiency and improve drug sensitivity, we successfully designed and prepared a novel TMZ nanocapsule (ApoE-MT/siPKM2 NC) for the combined delivery of siPKM2 and TMZ...
April 23, 2024: Advanced Materials
https://read.qxmd.com/read/38651235/custom-design-of-multi-stimuli-responsive-degradable-silica-nanoparticles-for-advanced-cancer-specific-chemotherapy
#8
REVIEW
Junjie Zhang, Jiani Zhou, Longguang Tang, Jiayi Ma, Ying Wang, Hui Yang, Xiaoxiao Wang, Wenpei Fan
Chemotherapy is crucial in oncology for combating malignant tumors but often encounters obatacles such as severe adverse effects, drug resistance, and biocompatibility issues. The advantages of degradable silica nanoparticles in tumor diagnosis and treatment lie in their ability to target drug delivery, minimizing toxicity to normal tissues while enhancing therapeutic efficacy. Moreover, their responsiveness to both endogenous and exogenous stimuli opens up new possibilities for integrating multiple treatment modalities...
April 23, 2024: Small
https://read.qxmd.com/read/38651178/survival-and-safety-analysis-of-covid-19-vaccine-in-chinese-patients-with-non-small-cell-lung-cancer
#9
JOURNAL ARTICLE
Wei Xu, Jing Zhao, Fang Luan, Zhizhao Zhang, Lei Liu, Hui Zhao, Bin Feng, Guobin Fu
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 disease (COVID-19) has caused a worldwide challenging and threatening pandemic. We aimed to assess the safety and efficacy of the COVID-19 vaccines in Non-Small Cell Lung Cancer (NSCLC) patients. METHODS: Patient self-reported adverse events related to vaccines were recorded by follow-up through a uniform questionnaire. Survival analysis was performed by Kaplan-Meier method. A multivariate analysis was performed by the Cox proportional hazard regression model to determine the effect of each variable on the survival of lung cancer patients...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38651037/cutaneous-manifestations-of-systemic-methotrexate-toxicity
#10
JOURNAL ARTICLE
Shivani Jain, Hunter J Pyle, Jessica C Evans, Whitney Gao, Melissa M Mauskar
No abstract text is available yet for this article.
June 2024: JAAD international
https://read.qxmd.com/read/38650940/longitudinal-cytokine-and-multi-modal-health-data-of-an-extremely-severe-me-cfs-patient-with-hsd-reveals-insights-into-immunopathology-and-disease-severity
#11
JOURNAL ARTICLE
Fereshteh Jahanbani, Justin Cyril Sing, Rajan Douglas Maynard, Shaghayegh Jahanbani, Janet Dafoe, Whitney Dafoe, Nathan Jones, Kelvin J Wallace, Azuravesta Rastan, Holden T Maecker, Hannes L Röst, Michael P Snyder, Ronald W Davis
INTRODUCTION: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) presents substantial challenges in patient care due to its intricate multisystem nature, comorbidities, and global prevalence. The heterogeneity among patient populations, coupled with the absence of FDA-approved diagnostics and therapeutics, further complicates research into disease etiology and patient managment. Integrating longitudinal multi-omics data with clinical, health,textual, pharmaceutical, and nutraceutical data offers a promising avenue to address these complexities, aiding in the identification of underlying causes and providing insights into effective therapeutics and diagnostic strategies...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38650683/wet-adhesive-hydrogels-based-on-niobium-carbide-for-experimental-research-of-oral-mucosal-impairment
#12
JOURNAL ARTICLE
Jiayuan Chen, Junyu Ren, Yingjie Wu, Narisu Hu, Fang Zhao, Lin Zhang
Oral mucosal impairment is a prevalent oral disease that frequently causes pain for patients. Conventional treatments have limited effectiveness and can cause adverse reactions. Furthermore, the moist and dynamic nature of the oral mucosal environment makes persistent adherence of conventional materials challenging, which can affect treatment efficacy. In this study, we investigated the potential of a NbC/TA-GelMA hydrogel system, where niobium carbide (NbC) and tannic acid (TA) were added to gelatin methacryloyl (GelMA), for repairing oral mucosal impairment...
April 16, 2024: RSC Advances
https://read.qxmd.com/read/38650404/-antibacterial-prophylaxis-with-fosfomycin-at-the-time-of-the-urethral-catheter-removal-after-radical-prostatectomy-prospective-randomized-trial
#13
JOURNAL ARTICLE
I Veliev E, A Sokolov E, Yu Metelev A, N Aliev E, S Polyakova A, V Ivkin E
AIM: To evaluate the effect of antibacterial prophylaxis using oral fosfomycin during the removal of a urethral catheter after radical prostatectomy on the development of urinary tract infection, severity of leukocyturia and bacteriuria, as well as the severity of lower urinary tract symptoms. MATERIALS AND METHODS: A single-center, non-blind, prospective, randomized controlled trial was carried out. The main group included 40 patients, and the control group included 37 patients...
March 2024: Urologii︠a︡
https://read.qxmd.com/read/38650403/-analysis-of-the-prevalence-of-nonspecific-urinary-tract-infection-in-patients-with-tuberculosis-among-residents-of-the-bukhara-region-of-the-republic-of-uzbekistan
#14
JOURNAL ARTICLE
R Rashidov Z, I Azimov S
AIM: To analyze the prevalence of nonspecific UTI in patients with tuberculosis and to evaluate the efficiency of therapy and prevention measures. MATERIAL AND METHODS: A total of 936 patients with tuberculosis of various localizations aged from 18 to 96 years were examined. There were 447 men (47.8%) and 489 women (52.2%). A diagnosis of nonspecific UTI was done using following criteria: the presence of characteristic symptoms, leukocyturia and bacteriuria detected by microscopic examination of the urine sediment, positive urine culture for nonspecific species, negative urine tests for Mycobacterium tuberculosis...
March 2024: Urologii︠a︡
https://read.qxmd.com/read/38649880/transient-pulmonary-and-gastric-bleeding-after-iopamidol-administration-in-a-patient-with-marginal-zone-lymphoma-a-case-report
#15
JOURNAL ARTICLE
Weixian Xu, Miaozhen Chen, Songtao Liu, Yi Su, Yunhai Zhang
BACKGROUND: Iopamidol is a non-ionic, water-soluble iodine contrast agent that is considered safe for intravenous or intra-arterial administration and is widely used both in the general population and in patients undergoing oncological treatment. While adverse reactions to iopamidol have been documented, to date, no pulmonary and gastric hemorrhages induced by iopamidol have been reported in oncology patients. We report the first case of this complication. CASE PRESENTATION: We report the case of a 60-year-old woman with marginal zone lymphoma who was receiving antineoplastic therapy...
April 22, 2024: BMC Pulmonary Medicine
https://read.qxmd.com/read/38649528/advancing-pain-management-for-extremity-trauma-the-evolution-of-ultrasound-guided-nerve-blocks-for-patients-in-the-supine-position-in-trauma-centers
#16
REVIEW
Yuefeng Huaguo, Shuai Kang, Li Hu, Hongmei Zhou
PURPOSE: Trauma, particularly extremity trauma, poses a considerable challenge in healthcare, especially among young adults. Given the severity of patient pain and the risks associated with excessive opioid use, managing acute pain in trauma centers is inherently complex. This study aims to investigate the application and benefits of ultrasound-guided nerve blocks for early pain management in patients with extremity trauma positioned supine. METHODS: A comprehensive literature review was conducted to assess the effectiveness and advantages of ultrasound-guided peripheral nerve blocks in the acute pain management of extremity trauma patients in the supine position...
April 22, 2024: European Journal of Trauma and Emergency Surgery: Official Publication of the European Trauma Society
https://read.qxmd.com/read/38649522/ensemble-plus-final-results-of-shorter-ocrelizumab-infusion-from-a-randomized-controlled-trial
#17
JOURNAL ARTICLE
Hans-Peter Hartung, Thomas Berger, Robert A Bermel, Bruno Brochet, William M Carroll, Trygve Holmøy, Rana Karabudak, Joep Killestein, Carlos Nos, Francesco Patti, Amy Perrin Ross, Ludo Vanopdenbosch, Timothy Vollmer, Regine Buffels, Monika Garas, Karen Kadner, Marianna Manfrini, Qing Wang, Mark S Freedman
INTRODUCTION: Ocrelizumab is an approved intravenously administered anti-CD20 antibody for multiple sclerosis (MS). The safety profile and patient preference for conventional versus shorter ocrelizumab infusions were investigated in the ENSEMBLE PLUS study. METHODS: ENSEMBLE PLUS was a randomized, double-blind substudy to the single-arm ENSEMBLE study (NCT03085810), comparing outcomes in patients with early-stage relapsing-remitting MS receiving ocrelizumab 600 mg over the approved 3...
April 22, 2024: Journal of Neurology
https://read.qxmd.com/read/38649128/management-of-systemic-inflammatory-response-syndrome-after-cardiovascular-interventions-diagnostic-prognostic-and-therapeutic-implications
#18
REVIEW
Carlo Mannina, Annapoorna Kini, Andreina Carbone, Eric Neibart, Eduardo Bossone, Francesca Romana Prandi, Rami Tadros, Giovanni Esposito, Raimund Erbel, Samin K Sharma, Stamatios Lerakis
A substantial number of patients may experience a systemic inflammatory response syndrome (SIRS) and related adverse events after transcatheter aortic valve implantation and endovascular aortic aneurysm repair. Although a clear etiology has not been established, endothelial disruption and tissue-ischemic response secondary to the foreign material may represent the trigger events. A latency period (0-48 hours) may occur between the initial injury and onset of symptoms mirroring an initial local response followed by a systemic response...
April 20, 2024: American Journal of Cardiology
https://read.qxmd.com/read/38648910/sarcoid-like-reactions-to-immune-checkpoint-inhibitors-incidence-treatment-course-and-impact-on-cancer-progression-and-survival
#19
JOURNAL ARTICLE
Hannah Smith, Robert Easterling, Jianing Ma, Meghana Moodabagil, Alexa Meara, Dwight H Owen, Elliot Crouser, Arindam Singha, Kevin Ho
INTRODUCTION: Sarcoid-like reactions (SLRs) to immune checkpoint inhibitors (ICIs) are a rare but increasingly recognized immune-related adverse event of which the clinical significance is unclear. METHODS: We conducted a retrospective cohort study at a tertiary academic center of consecutive patients who received at least one dose of ICI from 2013-2020. Patient characteristics, risk factors, and outcomes were compared between patients with and without SLR following ICI treatment...
April 20, 2024: Respiratory Medicine
https://read.qxmd.com/read/38648870/aluminum-and-abc-transporter-activity
#20
JOURNAL ARTICLE
Goezde Oezen, Lisa Kraus, Eva-Maria Schentarra, Jan Stephan Bolten, Joerg Huwyler, Gert Fricker
Aluminum is the third most common element on Earth´s crust and despite its wide use in our workaday life it has been associated with several health risks after overexposure. In the present study the impact of aluminum salts upon ABC transporter activity was studied in the P-GP-expressing human blood-brain barrier cell line hCMEC/D3, in MDCKII cells overexpressing BCRP and MRP2, respectively, and in freshly isolated, functionally intact kidney tubules from Atlantic killifish (Fundulus heteroclitus), which express the analog ABC transporters, P-gp, Bcrp and Mrp2...
April 20, 2024: Environmental Toxicology and Pharmacology
keyword
keyword
118146
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.